This is a golden age of heart transplantation — and the Heart Transplant Program at the Cedars-Sinai Heart Institute is a trailblazer for the procedure in the United States and around the world.
For four years in a row, the program has completed more adult heart transplants than any other medical facility in the nation.
Led by Jon Kobashigawa, MD, our expert team offers the most sophisticated options available in cardiac support devices, surgical techniques and anti-rejection technologies. Our responsive, interdisciplinary staff provides patients with financial and psychosocial support to ease the transition to a donor heart.
In the five-year period from 2010 through 2014, our comprehensive approach to care has led to 91 percent of our patients living more than a year after their heart transplant — surpassing the projected survival rate determined by the United Network of Organ Sharing (UNOS).
As a part of the world-class Heart Institute, our physicians work closely with a suite of other programs, including the Heart Failure Program, Mechanical Circulatory Support Program, Interventional Cardiology and the Regenerative Medicine Clinic.
More than a thousand patients have undergone transplants at Cedars-Sinai since the Heart Transplant Program was established in 1988, according to UNOS. Because we treat more of these patients than any other center in the United States, we can tailor our approach to each individual's needs, resulting in outstanding outcomes.
Kevin O'Neil has nearly died from AL amyloidosis, but with a heart-kidney transplant from the Heart Transplant Program he continues his fight for life.Read Full Story
Anti-Antibody Solution May Reduce Rejection After Transplant
The Cedars-Sinai Heart Transplant Program is testing a new medication that could help patients whose bodies are likely to reject a donor organ. The drug blunts the ability of antibodies to destroy the new heart.Learn More